Exklusiver Live-Stream direkt von der World of Trading - 2 Tage mit einzigartigen Themen und Experten. Kostenlos teilnehmen + Videos erhalten. -w-
18.01.2018 23:30:00

Fiera Capital reports December 2017 preliminary assets under management

/NOT FOR DISTRIBUTION TO U.S. NEWS WIRE SERVICES OR DISSEMINATION IN THE UNITED STATES/

MONTREAL, Jan. 18, 2018 /CNW Telbec/ - Fiera Capital Corporation (TSX: FSZ) ("Fiera Capital" or "the Firm"), a leading independent asset management firm, today reported its preliminary estimate of assets under management ("AUM") of approximately C$128.9 billion as at December 31, 2017.

The distribution of AUM by clientele is comprised of C$68.0 billion for the Institutional sector, C$26.3 billion for Private Wealth, and C$34.6 billion for the Retail segment. Compared to C$123.0 billion as at September 30, 2017, the C$5.9 billion increase in AUM is mainly attributable to market performance and a strategic acquisition.

About Fiera Capital Corporation

Fiera Capital is a leading independent asset management firm with approximately C$128.9 billion in assets under management as of December 31, 2017. The Firm provides institutional, retail and private wealth clients with access to full-service integrated money management solutions across traditional and alternative asset classes. Clients and their portfolios derive benefit from Fiera Capital's depth of expertise, diversified offerings and outstanding service. Fiera Capital trades under the ticker FSZ on the Toronto Stock Exchange. www.fieracapital.com

In the U.S., asset management services are provided by the Firm's U.S. affiliates who are investment advisers that are registered with the U.S. Securities and Exchange Commission (SEC). Registration with the SEC does not imply a certain level of skill or training.

Additional information about Fiera Capital Corporation, including the Firm's annual information form, is available on SEDAR at www.sedar.com.

 

SOURCE Fiera Capital Corporation

Nachrichten zu Oncolytics Biotech Incmehr Nachrichten

Keine Nachrichten verfügbar.

Analysen zu Oncolytics Biotech Incmehr Analysen

Eintrag hinzufügen
Hinweis: Sie möchten dieses Wertpapier günstig handeln? Sparen Sie sich unnötige Gebühren! Bei finanzen.net Brokerage handeln Sie Ihre Wertpapiere für nur 5 Euro Orderprovision* pro Trade? Hier informieren!
Es ist ein Fehler aufgetreten!

Aktien in diesem Artikel